Human Molecular Genetics Advance Access originally published online on August 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, No. 20 2587-2597
DOI: 10.1093/hmg/ddg269
© 2003 Oxford University Press
The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI
1Rose Moss Laboratory for Neurogenetics, Parkinson's and Related Diseases, Burns and Allen Research Institute, Los Angeles, CA, USA, 2Division of Neurology, 8700 Beverly Blvd, Davis 2094E, Cedars-Sinai Medical Center, Los Angeles, CA, USA and 3Department of Neurobiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
Received May 14, 2003; Accepted August 1, 2003
Inactivating mutations of the gene encoding parkin are responsible for some forms of autosomal recessive juvenile Parkinson disease. Parkin is a ubiquitin ligase that ubiquitinates misfolded proteins targeted for the proteasome-dependent protein degradation pathway. Using the yeast two-hybrid system and co-immunoprecipitation methods, we identified synaptotagmin XI as a protein that interacts with parkin. Parkin binds to the C2A and C2B domains of synaptotagmin XI resulting in the polyubiquitination of synaptotagmin XI. Truncated and missense mutated parkins reduce parkin-sytXI binding affinity and ubiquitination. Parkin-mediated ubiquitination also enhances the turnover of sytXI. In sporadic PD brain sections, sytXI was found in the core of the Lewy bodies. Since synaptotagmin XI is a member of the synaptotagmin family that is well characterized in their importance for vesicle formation and docking, the interaction with this protein suggests a role for parkin in the regulation of the synaptic vesicle pool and in vesicle release. Loss of parkin could thus affect multiple proteins controlling vesicle pools, docking and release and explain the deficits in dopaminergic function seen in patients with parkin mutations.
* To whom correspondence should be addressed at: 8700 Beverly Blvd, Davis Research Blvd, Room 2091, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Tel: +1 3104235166; Fax: +1 8108212407; Email: pulst{at}cshs.org
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. A. Hristova, S. A. Beasley, R. J. Rylett, and G. S. Shaw Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin J. Biol. Chem., May 29, 2009; 284(22): 14978 - 14986. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Lu, S. M. Fleming, B. Meurers, L. C. Ackerson, F. Mortazavi, V. Lo, D. Hernandez, D. Sulzer, G. R. Jackson, N. T. Maidment, et al. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein J. Neurosci., February 18, 2009; 29(7): 1962 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Helton, T. Otsuka, M.-C. Lee, Y. Mu, and M. D. Ehlers Pruning and loss of excitatory synapses by the parkin ubiquitin ligase PNAS, December 9, 2008; 105(49): 19492 - 19497. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation J. Biol. Chem., April 27, 2007; 282(17): 12842 - 12850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Yi and M. D. Ehlers Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function Pharmacol. Rev., March 1, 2007; 59(1): 14 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Beasley, V. A. Hristova, and G. S. Shaw From the Cover: Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease PNAS, February 27, 2007; 104(9): 3095 - 3100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Feng Microtubule: A Common Target for Parkin and Parkinson's Disease Toxins Neuroscientist, December 1, 2006; 12(6): 469 - 476. [Abstract] [PDF] |
||||
![]() |
K. Willeumier, S. M Pulst, and F. E Schweizer Proteasome inhibition triggers activity-dependent increase in the size of the recycling vesicle pool in cultured hippocampal neurons. J. Neurosci., November 1, 2006; 26(44): 11333 - 11341. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Sriram, X. Li, H. S. Ko, K. K.K. Chung, E. Wong, K. L. Lim, V. L. Dawson, and T. M. Dawson Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin Hum. Mol. Genet., September 1, 2005; 14(17): 2571 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Ko, R. von Coelln, S. R. Sriram, S. W. Kim, K. K. K. Chung, O. Pletnikova, J. Troncoso, B. Johnson, R. Saffary, E. L. Goh, et al. Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death J. Neurosci., August 31, 2005; 25(35): 7968 - 7978. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yang, Q. Jiang, J. Zhao, Y. Ren, M. D. Sutton, and J. Feng Parkin Stabilizes Microtubules through Strong Binding Mediated by Three Independent Domains J. Biol. Chem., April 29, 2005; 280(17): 17154 - 17162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Greene, A. J. Whitworth, L. A. Andrews, T. J. Parker, and L. J. Pallanck Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis Hum. Mol. Genet., March 15, 2005; 14(6): 799 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhong, Y. Tan, A. Zhou, Q. Yu, and J. Zhou RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity J. Biol. Chem., March 11, 2005; 280(10): 9425 - 9430. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Moore, L. Zhang, J. Troncoso, M. K. Lee, N. Hattori, Y. Mizuno, T. M. Dawson, and V. L. Dawson Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Hum. Mol. Genet., January 1, 2005; 14(1): 71 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Coelln, B. Thomas, J. M. Savitt, K. L. Lim, M. Sasaki, E. J. Hess, V. L. Dawson, and T. M. Dawson Loss of locus coeruleus neurons and reduced startle in parkin null mice PNAS, July 20, 2004; 101(29): 10744 - 10749. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Marin, J. I. Lucas, A.-C. Gradilla, and A. Ferrus Parkin and relatives: the RBR family of ubiquitin ligases Physiol Genomics, May 19, 2004; 17(3): 253 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Mata, P. J. Lockhart, and M. J. Farrer Parkin genetics: one model for Parkinson's disease Hum. Mol. Genet., April 1, 2004; 13(90001): R127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M.K. Muqit, S. M. Davidson, M. D. Payne Smith, L. P. MacCormac, S. Kahns, P. H. Jensen, N. W. Wood, and D. S. Latchman Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival Hum. Mol. Genet., January 1, 2004; 13(1): 117 - 135. [Abstract] [Full Text] [PDF] |
||||






